By Jeff Overley ( August 12, 2015, 9:03 PM EDT) -- A Maryland federal judge has axed Mallinckrodt Inc.'s lawsuit challenging a change to its therapeutic equivalence rating for a generic version of Janssen Pharmaceuticals Inc.'s Concerta, finding no procedural or constitutional violations by the U.S. Food and Drug Administration in a ruling unsealed Wednesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.